Intracellular Return On Equity vs. Current Valuation
| ITCI Stock | USD 84.65 0.51 0.61% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.24) | Current Value (0.25) | Quarterly Volatility 0.30646318 |
For Intracellular profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intracellular to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intracellular Th utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intracellular's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intracellular Th over time as well as its relative position and ranking within its peers.
Intracellular |
Intracellular's Revenue Breakdown by Earning Segment
Check out Risk vs Return Analysis.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.87) | Revenue Per Share 6.096 | Quarterly Revenue Growth 0.39 | Return On Assets (0.07) | Return On Equity (0.1) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Intracellular Th Current Valuation vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Intracellular's current stock value. Our valuation model uses many indicators to compare Intracellular value to that of its competitors to determine the firm's financial worth. Intracellular Th is rated below average in return on equity category among its peers. It is rated second overall in current valuation category among its peers . As of now, Intracellular's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intracellular's earnings, one of the primary drivers of an investment's value.Intracellular Current Valuation vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Intracellular |
| = | -0.099 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Intracellular |
| = | 8.21 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Intracellular Current Valuation vs Competition
Intracellular Th is rated second overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 41.54 Billion. Intracellular retains roughly 8.21 Billion in current valuation claiming about 20% of equities under Health Care industry.
Intracellular Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Intracellular, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Intracellular will eventually generate negative long term returns. The profitability progress is the general direction of Intracellular's change in net profit over the period of time. It can combine multiple indicators of Intracellular, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 104 K | 109.2 K | |
| Operating Income | -159.4 M | -167.4 M | |
| Income Before Tax | -139 M | -146 M | |
| Net Loss | -230.6 M | -219.1 M | |
| Net Loss | -139.7 M | -146.7 M | |
| Income Tax Expense | 636 K | 667.8 K | |
| Total Other Income Expense Net | 20.3 M | 21.4 M | |
| Net Loss | -139.7 M | -146.7 M | |
| Non Operating Income Net Other | 8.5 M | 8.9 M | |
| Interest Income | 20.3 M | 21.4 M | |
| Net Interest Income | 20.3 M | 21.4 M | |
| Change To Netincome | 49.6 M | 52 M | |
| Net Loss | (1.46) | (1.53) | |
| Income Quality | 0.89 | 0.72 | |
| Net Income Per E B T | 1.00 | 0.80 |
Intracellular Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Intracellular. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intracellular position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intracellular's important profitability drivers and their relationship over time.
Use Intracellular in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intracellular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will appreciate offsetting losses from the drop in the long position's value.Intracellular Pair Trading
Intracellular Th Pair Trading Analysis
The ability to find closely correlated positions to Intracellular could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intracellular when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intracellular - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intracellular Th to buy it.
The correlation of Intracellular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intracellular moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intracellular Th moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intracellular can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Intracellular position
In addition to having Intracellular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cigarettes Thematic Idea Now
Cigarettes
Tobacco makers and distributors across globe. The Cigarettes theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
To fully project Intracellular's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Intracellular Th at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Intracellular's income statement, its balance sheet, and the statement of cash flows.